Skip to main content
Year archive

SUPHA PHARMACHEM LIMITED — 2021 filings

All 59 regulatory filings released by SUPHA PHARMACHEM LIMITED (539561) in 2021, sourced directly from the official regulator.

59 Filings
2021 Period
2021 filings (59)
Filing Released Lang
Closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015.
Regulatory Filings
2021-12-29 English
News Paper Clippings regarding publication of Notice of the Board Meeting scheduled to be held on November 12, 2021 for approval of unaudited Financial Result for the 2nd Quarter and half ....
Regulatory Filings
2021-11-15 English
Unaudited financial results for the quarter and half year ended 30.09.2021
Regulatory Filings
2021-11-12 English
Outcome of the Board Meeting held on 12.11.2021
Regulatory Filings
2021-11-12 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2021 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2021-11-02 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2021 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2021-10-26 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2021.
Regulatory Filings
2021-10-08 English
E-Voting Result and Scrutinizer Report for the 32nd Annual General Meeting of the Company held on 30.09.2021
Regulatory Filings
2021-10-01 English
Outcome / Proceedings of 32nd Annual General Meeting held on September 30, 2021
Regulatory Filings
2021-09-30 English
Intimation of closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015.
Regulatory Filings
2021-09-29 English
Announcement under Regulation 30(LODR)- Newspaper Publication after posting Annual Report.
Regulatory Filings
2021-09-04 English
Regulation 34(1) Annual Report and Notice of AGM
Regulatory Filings
2021-09-02 English
Announcement under Regulation 30(LODR) of Newspaper Advertisement for 32nd AGM
Regulatory Filings
2021-09-01 English
32nd Annual General Meeting (AGM) of the Company will be held on Thursday, 30th September, 2021 at 10.00 am through VC/OAVM. Book Closure: From Friday 24th September, 2021 ....
Regulatory Filings
2021-08-30 English
Intimation of 32nd Annual General Meeting scheduled to be held on Thursday, September 30, 2021.
Regulatory Filings
2021-08-30 English
Announcement under Regulation 30 (LODR) - Intimation of appointment of new RTA in place of Old RTA.
Regulatory Filings
2021-08-21 English
We wish to inform you that the company is in process of changing its existing Registrar and Share Transfer Agent(RTA) i.e. Beetal Financial & Computer Services Private Limited. ....
Regulatory Filings
2021-07-28 English
The Company has appointed Ms. Ashvini Dhuri (ICSI Membership No. 66051) as a Company Secretary & Compliance Officer of the Company w.e.f. 21.07.2021.
Regulatory Filings
2021-07-21 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2021.
Regulatory Filings
2021-07-20 English
Newspaper Clippings for publication of Unaudited Financial Results for the quarter ended June 30, 2021.
Regulatory Filings
2021-07-12 English
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary and Compliance Officer
Regulatory Filings
2021-07-07 English
Unaudited Financial Results for the quarter ended 30.06.2021
Regulatory Filings
2021-07-07 English
Outcome of the board meeting held on 07.07.2021
Regulatory Filings
2021-07-07 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2021 ,inter alia, to consider and approve the Unaudited Standalone ....
Regulatory Filings
2021-07-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-07-01 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-07-01 English
Intimation of closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2021-06-28 English
Pursuant to SEBI Circular bearing No. CIR/CFD/CMD1/27/2019 dated February 08, 2019, please find enclosed herewith the Annual Secretarial Compliance Report for the year ended 31st March, 2021
Regulatory Filings
2021-06-28 English
Pursuant to Regulation 8(2) of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, please find enclosed company's 'Code of Practices and Procedures ....
Regulatory Filings
2021-06-21 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-06-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-06-17 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-06-16 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-06-14 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Resignation of Managing Director
Regulatory Filings
2021-05-20 English
Intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 - Change in Directorate
Regulatory Filings
2021-05-20 English
Outcome of the Board Meeting held on 20.05.2021
Regulatory Filings
2021-05-20 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2021 ,inter alia, to consider and approve 1. appointment of Mr. Vilas ....
Regulatory Filings
2021-05-17 English
Announcement under Regulation 30 (LODR)
Regulatory Filings
2021-05-14 English
We wish to inform you that the board of directors of the company at its meeting held on 11.05.2021, has approved shifting of the registered office of the company from existing office situated ....
Regulatory Filings
2021-05-12 English
Results- Audited Financial Results for the quarter and year ended 31.03.2021
Regulatory Filings
2021-05-11 English
Outcome of the Board Meeting held on 11.05.2021
Regulatory Filings
2021-05-11 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2021 ,inter alia, to consider and approve 1. the Audited Standalone ....
Regulatory Filings
2021-05-04 English
Certificate under Regulation 7(3) of the SEBI (LODR), Regulations, 2015 for the half year ended 31.03.2021
Regulatory Filings
2021-04-20 English
Certificate under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31.03.2021
Regulatory Filings
2021-04-20 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2021.
Regulatory Filings
2021-04-20 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-04-19 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-04-14 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-04-09 English
Intimation of closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading Regulations, 2015
Regulatory Filings
2021-04-02 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-03-26 English
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-03-26 English
The Exchange has received the revised disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-03-26 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-03-23 English
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Siddharth Shah
Regulatory Filings
2021-03-23 English
Unaudited Financial Results for the quarter ended December 31, 2020
Regulatory Filings
2021-02-12 English
Outcome of the Board Meeting held on 12.02.2021
Regulatory Filings
2021-02-12 English
News Paper Clippings for publication of Notice of the Board Meeting scheduled to be held on 12th February 2021 for approval of unaudited Financial Results for the 3rd quarter ended 31st ....
Regulatory Filings
2021-02-08 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2021 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2021-02-03 English
Please find enclosed herewith Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2020.
Regulatory Filings
2021-01-21 English